Fig. 4
From: Immunological classification of gliomas based on immunogenomic profiling
Comparisons of survival prognosis between the glioma immune subtypes and between high-immune-score (upper third) and low-immune-score (bottom third) gliomas. Kaplan–Meier curves showing that immunity-low had better overall and/or disease-free survival than immunity-medium and immunity-high (a) and that high-immune-score gliomas had a worse survival prognosis than low-immune-score gliomas (b) in the five glioma datasets. The log-rank test p values are shown